AI-designed universal vaccine enters human trials, aiming to protect against multiple virus families
By
Marta Iraola Iribarren
Lightly browned and well buttered. A solid pick from the rack.
Summary
British researchers at Cambridge and Southampton universities have developed the first AI-designed vaccine to be tested in humans. This "universal vaccine" aims to protect against entire families of viruses (like Influenza, Coronaviruses, and Ebola) that evolve rapidly. The current reactive vaccine system struggles to keep pace with viral evolution, and this AI-driven approach could transform pandemic preparedness by proactively designing vaccines against unknown future viruses.
Key quotes
· 2 pulledViruses like Influenza, Coronaviruses and the Ebola group are evolving continuously, and by the time vaccines are rolled out, they may be poorly matched — the current 'reactive' vaccine system struggles to keep pace
The current 'reactive' vaccine system struggles to keep pace
You might also wanna read
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac
med.stanford.edu·2mo ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
bbc.com·3mo ago
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·10mo ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·9mo ago
OpenAI launches Rosalind Biodefense to provide trusted AI access for biodefense and pandemic preparedness
OpenAI has launched Rosalind Biodefense, an initiative expanding trusted access to GPT-Rosalind—a specialized AI model—for vetted developers
openai.com·8d ago
AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
The Verge·2d agoAI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
theverge.com·2d ago